CAMP4 Therapeutics Corporation (NASDAQ:CAMP) IPO will take place October, 11 on the NASDAQ exchange under the ticker CAMP.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on April 09, 2025.
See also: Benzinga IPO Calendar
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
